Dr. Andrew Howard

Dr. Howard currently serves as educational coordinator of the training component of the British Columbia Neuropsychiatry Program, one of two accredited Neuropsychiatry fellowship programs in Canada.  He is the Associate Program Director of the psychiatry residency program at UBC, organizing and overseeing the academic curriculum. As Clinical Professor in the Department of Psychiatry at the University of British Columbia, his current interests include: optimal assessment and management of patients with somatic symptom disorders and functional neurological disorders; intensive rehabilitation of individuals with neurological conditions with psychiatric symptoms (including traumatic brain injury and movement disorders); clinical research in deep brain stimulation of refractory depression and movement disorders, functional cognitive disorders after mild traumatic brain injury and head injury, and pharmacotherapy of anxiety in Parkinson’s.  He acts as the consultant psychiatrist and clinical researcher to movement disorder patients at the University of British Columbia at the Centre for Huntington Disease and the Pacific Parkinson’s Research Centre.

Dr. Andrew Howard studied psychology during an undergraduate degree at Harvard University, with a specific interest in neurophysiology, and medicine at Queen’s University with specific interest in psychosomatic medicine.  Since that time, he returned to Vancouver to complete a residency in psychiatry and a fellowship in clinical neuropsychiatry.  He is certified in Behavioral Neurology and Neuropsychiatry by the United Council of Neurologic Subspecialties.

• Rioux M, Mamman R, Byworth MT, Panenka WJ, Howard AK, Perez DL, Schmidt J, Courchesne C, LeMoult J, Heran MKS, & ND Silverberg. Pilot feasibility randomized controlled trial of cognitive-behavioural therapy for functional cognitive disorder after concussion. BMJ Neurology Open 2024; 6:e000666. doi:10.1136/bmjno-2024-000666
• Lee HJ, Tsang VWI, Chai BS, Lin MCQ, Howard A, Uy C, Elefante JO. Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review. Journal of Psychoactive Drugs; June 29 2023: 1-15.
• Colijn MA, Torres IJ, Menon M, Howard A, Honer WG, Stowe RM. Progressive neurocognitive decline in schizophrenia: A diagnostic dilemma for clinicians. Schizophrenia Research; March 2022: 241: 59-62.
• Picon EL, Todorova E, Palombo DJ, Perez DL, Howard A, Silverberg ND. Memory perfectionism is associated with persistent memory complaints after concussion. Archives of Clinical Neuropsychology; Sept 2022: 37 (6): 1177-84.
• Scamvougeras A, Howard A. Somatic Symptom Disorder, Medically Unexplained Symptoms, Somatoform Disorders, Functional Neurological Disorder: How DSM-5 Got It Wrong. Can J Psychiatry; 2020 Mar 19, 1-5.
• Stubbs JL, Green KE, Howard A, Silverberg N, Dhariwal A, Pearce HL, Purcell V, Panenka WJ. Atypical somatic symptoms in adults with prolonged recovery from mild traumatic brain injury. Front Neurol; 2020 Feb 4; 11: 43.
• Scamvougeras A, Howard A. Understanding and Managing Somatoform Disorders:
  A Guide for Clinicians. AJKS Publishing; Vancouver, 2018.
• Schwaiger T, Silverberg N, Panenka W, Howard A. Concussion management: time to give “brain rest” a rest.“This Changed My Practice” (May 2, 2018); UBC CPD Faculty of Medicine.
• Tham JCW, Howard A, Ilcewicz-Klimek M, Hurwitz TA. Bifrontal Electoconvulsive Therapy in a Patient with Subcallosal Cingulate Deep Brain Stimulation for Depression. J ECT 33(4): 39-40, 2017.
• Howard, AK; Krishnamoorthy A; Leavitt BR; Raymond LA; Weissman CR. Treatment of Huntington Disease and Comorbid Trichotillomania With Aripiprazole. J Neuropsychi Clin Neurosci 27(3):e211-2, 2015.
• Bogod NM, Sinden M, Woo C, Defreitas VG, Torres IJ, Howard AK, Ilcewicz-Klimek MI, Honey CR, Yatham LN, Lam RW (2014). Long-term neuropsychological safety of subgenual gyrus deep brain stimulation for treatment-resistant depression. J Neuropsychi Clin Neurosci 26 (2): 126-133.
• Howard, A. Managing the complicated somatoform disorder patient. “This Changed My Practice” (September 10, 2013); UBC CPD Faculty of Medicine. Lozano AM et al. (2012). A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg 116; 315-322.
• Howard A et al. (2012). Deep brain stimulation interruption and suicidality. J Neurosurg 116: 467-468.
• Howard AK and M Zurowski (2010). Bradyphrenia. In: Kompoliti K, and Verhagen Metman L (eds.) Encyclopedia of Movement Disorders, vol 2, pp 161-165 Oxford: Academic Press.
• Howard AK and M Zurowski (2010). Neuroleptics and Movement Disorders.
  In: Kompoliti K, and Verhagen Metman L (eds.) Encyclopedia of Movement
  Disorders, vol 2, pp 282-291 Oxford: Academic Press.
• Lam RW, Chan P, and A Howard. Somatic Treatments for Bipolar Disorder in Yatham LN and Kusumakar V, Bipolar Disorder, 2nd ed. New York: Routledge, 2009.
• Hadjipavlou G, Lai A, Baer S, & A. Howard (2008). Selective Sound Intolerance and Emotional Distress: What Every Clinician Should Hear. Psychosomatic Medicine; 70: 737-40.
• Howard, A.K. et al. Donepezil for memory dysfunction in schizophrenia. Journal of Psychopharmacology, 16 (3), 2002